SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000929638-21-000086
Filing Date
2021-01-21
Accepted
2021-01-21 16:20:01
Documents
2
Group Members
3D OPPORTUNITY MASTER FUND

Document Format Files

Seq Description Document Type Size
1 sc13d.htm SC 13D 68658
2 JOINT FILING AGREEMENT exhibit3.htm EX-99.3 6477
  Complete submission text file 0000929638-21-000086.txt   76734
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Subject) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-81409 | Film No.: 21542215
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 NORTH BRIDGE ROAD #13-01 RAFFLES CITY TOWER SINGAPORE U0 179101
Business Address 250 NORTH BRIDGE ROAD #13-01 RAFFLES CITY TOWER SINGAPORE U0 179101 65 6819 0000
3D Investment Partners Pte. Ltd. (Filed by) CIK: 0001841538 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: SC 13D